Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-09-01 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: L'ARBRESLE (69210), Rhone
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PIOLAT : revenue, balance sheet and financial ratios
PHARMACIE PIOLAT is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in L'ARBRESLE (69210),
this company of category PME
shows in 2024 a net income positive of 235 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PIOLAT (SIREN 524937000)
Indicator
2024
2023
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
235 001 €
205 349 €
283 532 €
202 135 €
224 644 €
189 955 €
293 167 €
-187 416 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE PIOLAT generates positive net income of 235 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
235 001 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 52%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
52.499%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.243%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Debt ratio
479.082
267.127
214.932
156.366
120.05
89.688
72.942
52.499
Financial autonomy
15.887
24.911
29.566
36.29
41.538
47.72
52.688
59.243
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
52.52024
2021
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good
In 2024, the debt ratio of PHARMACIE PIOLAT (52.50) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.24%2024
2021
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+8 pts over 3 years
In 2024, the financial autonomy of PHARMACIE PIOLAT (59.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 173.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
173.603
Liquidity indicators evolution PHARMACIE PIOLAT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2023
2024
Liquidity ratio
181.309
208.467
273.588
226.016
195.091
205.323
184.458
173.603
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
173.62024
2021
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average-9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE PIOLAT (173.60) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE PIOLAT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE PIOLAT is estimated at
3 280 787 €
(range 2 284 688€ - 4 908 246€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2284k€3280k€4908k€
3 280 787 €Range: 2 284 688€ - 4 908 246€
NAF 5 année 2024
Valuation method used
Net Income Multiple
235 001 €
×
14.0x
=3 280 788 €
Range: 2 284 689€ - 4 908 246€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PIOLAT with other companies in the same sector:
The revenue of PHARMACIE PIOLAT is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE PIOLAT profitable?
Yes, PHARMACIE PIOLAT generated a net profit of 235 k€ in 2024.
Where is the headquarters of PHARMACIE PIOLAT ?
The headquarters of PHARMACIE PIOLAT is located in L'ARBRESLE (69210), in the department Rhone.
Where to find the tax return of PHARMACIE PIOLAT ?
The tax return of PHARMACIE PIOLAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PIOLAT operate?
PHARMACIE PIOLAT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart